Roche H1N1 flu test wins emergency clearance
This article was originally published in The Gray Sheet
Executive Summary
FDA grants emergency use authorization to Roche's RealTime Ready Influenza A/H1N1 Detection Set,which will allow clinicians to test for the presence of the 2009 H1N1 influenza virus collected via nasopharyngeal swabs, nasal swabs, washes and aspirates in clinical settings, and "augment existing testing capacity" for the H1N1 virus, FDA says in its Nov. 13 EUA letter. FDA has also granted emergency use authorization for use of Roche's Detection Set on the company's LightCycler 2.0 ("1The Gray Sheet" Aug. 24, 2009)
You may also be interested in...
Feds Seeking A Few Good Tests, And Masks, For Flu Season
With an especially challenging flu season expected this year, government officials are scrambling to evaluate the tools they have available to monitor, diagnose and limit spread of the virus
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.